Tag: Baudax Bio
Baudax Bio Announces Special Meeting of Shareholders to Vote on Proposed...
MALVERN, Pa., June 18, 2021 (GLOBE NEWSWIRE) -- Baudax Bio, Inc. (NASDAQ:BXRX), a pharmaceutical company focused on developing and commercializing innovative...
Baudax Bio Announces $11.9 Million Registered Direct Offering
MALVERN, Pa., May 31, 2021 (GLOBE NEWSWIRE) -- Baudax Bio, Inc. (NASDAQ:BXRX), a pharmaceutical company focused on developing and commercializing innovative...
Leading Independent Proxy Advisory Firm Glass Lewis & Co. Recommends Baudax...
MALVERN, Pa., May 12, 2021 (GLOBE NEWSWIRE) -- Baudax Bio, Inc. (NASDAQ:BXRX) (the “Company”), a pharmaceutical company focused on developing and...